Search Results

Refine Search

News & Features

Genomic innovations involve vast amounts of research, making patents, copyrights, and trade secrets vital, explains Olusola Tunmise-Ajani of Inventa International. 29 April 2025

Asia

How post-filing data rescued Novo Nordisk’s Ozempic patent in China

The Beijing IP court’s decision to revive a key semaglutide patent based on experimental data has far-reaching legal and economic implications, says Jennifer Che of Eagle IP 15 October 2024

Asia

How to navigate patent term adjustment in China

Recent updates to China’s patent law provide guidelines on PTA calculations, definitions of delays and challenging decisions, say Audrey Cheung, Yolanda Wang and Jennifer Che of Eagle IP. 8 October 2024

Americas

‘Masking only works for so long’: Working with ADHD

Being a lawyer with ADHD is far from easy due to widespread misconceptions about the condition but there are ways to offer support, says Lisa Mueller of Casimir Jones. 1 August 2024

Big Pharma

Amgen v Sanofi/Regeneron in Japan: Function, sequence, mechanism

Amgen patents declared valid in Germany and Japan have also been deemed invalid by the European Patent Office, US Supreme Court, and in a separate Japan decision: but why? Takanori Abe of Abe & Partners examines the details. 19 March 2024

Europe

‘We created law’: G1/24 and the creation of the ‘diamond standard’

The architect of an historic change in the way patent claims are interpreted explains what it means for AI drafting, and why more harmonisation may follow, reports Tom Phillips 3 July 2025

Europe

BMS unit loses cell therapy patent at European Patent Office

Board of Appeal upholds opposition challenge over added subject-matter claims | Dispute concerned patent relating to T cell therapeutic manufacturing methods. 3 July 2025

Americas

Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market

Biocon failed to provide critical information about proposed denosumab product, Amgen claims | Company expects ‘sales erosion’ of Prolia and XGEVA in 2025 driven by biosimilar competition | Sandoz launched interchangeable versions of bone drugs last month following settlement in 2024. 2 July 2025

Europe

Lord Justice Birss to become chancellor of the High Court

The prominent senior IP judge is known for his groundbreaking judgments on patents, AI and FRAND, such as Unwired Planet, Thaler's DABUS, and InterDigital. 2 July 2025

Americas

Bankruptcy judge approves $305m sale of genetics testing company

Judge says sale of genetic data is ‘scary proposition’ but that blanket ban could result in missed opportunities | Former CEO Anne Wojcicki will repurchase business that she co-founded and ran for years. 1 July 2025